Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_assertion description "[Glioma-related B7-H1 was identified as a strong inhibitor of CD4+ as well as CD8+ T-cell activation as assessed by increased cytokine production (IFN-gamma, interleukin-2, and interleukin-10) and expression levels of the T-cell activation marker (CD69) in the presence of a neutralizing antibody against B7-H1 (mAb 5H1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_assertion evidence source_evidence_literature NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_assertion SIO_000772 14612546 NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_assertion wasDerivedFrom befree-20150227 NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_assertion wasGeneratedBy ECO_0000203 NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP503474.RAf538wuGDY5H1dDV1HlzFKkIOvTwH4ItCbC6-paNkOrU130_provenance.